China-based startup Huahui Health has entered into a global exclusive option, license and collaboration agreement w...
China’s 2026 budget marks the beginning of the 15th Five-Year Plan, placing technology and innovation at the centr...
Chongqing Claruvis Pharmaceutical, a subsidiary of MingMed Biotechnology, has announced that the China's National M...
A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...
Biogen Inc. and TJ Biopharma have entered into a definitive agreement under which Biogen has agreed to acquire TJ B...
Santen Pharmaceutical Co. has announced that Santen China has entered into a distribution and promotion agreement with A...
China-based Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, ...
“Hong Kong is steadily evolving beyond its traditional identity as a gateway into China to become a strategic comm...
The Centre for Exercise Science and Medicine (CESAME), a flagship, transdisciplinary research hub at Hong Kong Baptist U...
As the pace of biotechnology research accelerates, companies are increasingly challenged to balance rapid innovation wit...
China-based Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with AbbVie, a global biopharm...
The event leverages Hong Kong’s strategic role as Asia’s hub for healthcare innovation and investment, foste...
China-based ATLATL Innovation Center, a global innovation platform for life science research and development, has announ...
US-based RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered bioproc...
As global competition for research talent accelerates and innovation ecosystems rapidly evolve, the development and rete...
Hangzhou Diagens Biotechnology has announced commencement of trading on the Main Board of The Stock Exchange of Hong Kon...
Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI) and automat...
Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven biotechnology...
Novartis is set to expand its presence in China with an investment exceeding RMB 3.3 billion to bolster R&D, product...
Hong Kong headquartered Insilico Medicine, a clinical-stage drug discovery and development company driven by genera...
The University of Hong Kong (HKU) and Suzhou Kowloon Hospital, under the Hong Kong Kowloon Group, have signed a Memorand...
Belief BioMed and Grand Life Sciences have signed an exclusive collaboration to commercialize BBM-H803 for hemophilia ...
Everest Medicines has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited. Under the ...
Sanofi, the French pharmaceutical leader, has inaugurated a state-of-the-art Innovation and Operations Center in Che...
AstraZeneca has announced plans to establish a commercial cell therapy manufacturing and supply base and innovation cent...
